Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05540314 · ClinicalTrials.gov registry record
Robotic Bariatric Database (RBD) Collaborative
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 100
- Enrollment target
NCT05540314: Completed study, sponsored by Methodist Health System.
NCT05540314 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05540314 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
With increased prevalence of obesity in the general population over the past 30 years, researchers have been focused on the development of new treatment options to achieve long-lasting weight loss. In 1991, the National Institutes of Health Conference Statement on Gastrointestinal Surgery for Severe Obesity developed a consensus stating that bariatric surgery was the most effective treatment for obesity since it is associated with good long-term results in terms of weight loss, glycemic control and decreased mortality. To collect and store clinical data related to the treatment outcomes of robotic bariatric surgery in order to develop an evidence base such that physicians can provide the best possible care to patients undergoing surgical weight loss interventions.
Primary Outcome
mm/dd/yyyy
Interventions
- PROCEDURE robotic bariatric surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-08-10 |
| Est. Completion | 2023-08-11 |
What the finished NCT05540314 record still lists
NCT05540314 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which robotic bariatric surgery is the first listed.
NCT05540314 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05540314 about?
NCT05540314 is a clinical study titled "Robotic Bariatric Database (RBD) Collaborative". With increased prevalence of obesity in the general population over the past 30 years, researchers have been focused on the development of new treatment options to achieve long-lasting weight loss. In 1991, the National Institutes of Health Conference Statement on Gastrointestinal Surgery for Severe...
What is the current status of trial NCT05540314?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2022-08-10. Estimated completion is 2023-08-11.
What interventions are being tested in trial NCT05540314?
The interventions under investigation include: robotic bariatric surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05540314?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI